Researchers at the TRIUMF laboratory in Vancouver, British Columbia, are in talks with several companies, including Cardinal Health, Covidien, GE Healthcare, Lantheus Medical Imaging and Nordion, over the business potential of producing the technetium-99m medical isotope using a cyclotron. The process utilizes molybdenum-100 and eliminates the need for a nuclear reactor.
Scientists move to commercialize new isotope production method
SmartBrief Job Listings for Health Care
|Vice President of Regulatory Affairs||
|Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX||
|Santa Clara, CA|
|Senior Director, Biostatistics||